Alembic

  • Market Cap: Small Cap
  • Industry: Realty
  • ISIN: INE426A01027
  • NSEID: ALEMBICLTD
  • BSEID: 506235
INR
103.54
0.91 (0.89%)
BSENSE

Sep 21, 03:30 PM

BSE+NSE Vol: 4.62 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

4.62 lacs (-48.68%) Volume

Shareholding (Jun 2026)

FII

1.25%

Held by 42 FIIs

DII

0.05%

Held by 0 DIIs

Promoter

70.88%

Why is Alembic Ltd falling/rising?

06-Sep-2026

As of 05-Sep, Alembic Ltd's stock price is rising to 111.41, reflecting a 1.79% increase. The stock has outperformed the Sensex significantly over the past week and month, driven by strong investor interest and positive long-term growth indicators.

As of 05-Sep, Alembic Ltd's stock price is rising, currently at 111.41, reflecting a change of 1.96 or 1.79% increase. This upward movement can be attributed to several factors. Over the past week, the stock has outperformed the Sensex, gaining 11.24% compared to a decline of 0.97% in the benchmark index. Additionally, in the last month, Alembic Ltd has shown a remarkable increase of 25.62%, while the Sensex has fallen by 2.44%.<BR><BR>Today's performance is particularly strong, as the stock opened with a gain of 2.24% and reached an intraday high of Rs 114.82, marking a 4.91% increase. The stock has been on a consecutive gain streak for three days, accumulating a total return of 12.83% during this period. Furthermore, Alembic Ltd is trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a strong bullish trend.<BR><BR>Investor participation has also increased significantly, with delivery volume rising by 616.2% against the 5-day average, suggesting heightened interest in the stock. The company is net-debt free and has demonstrated healthy long-term growth, with an operating profit growth rate of 48.23%. This performance has allowed Alembic Ltd to outperform the BSE500 over various time frames, including the last three years, one year, and three months.<BR><BR>Despite some negative factors, such as disappointing results in June and a high valuation compared to peers, the overall market sentiment appears to be positive, contributing to the stock's rise.

View full answer

Should I buy, sell or hold Alembic Ltd?

05-Sep-2026

Who are in the management team of Alembic?

01-Sep-2026

The management team of Alembic includes Chairman Chirayu R Amin, Managing Director & CEO Malika C Amin, and several directors, including independent members like C P Buch and Sameer Khera, among others. They are responsible for guiding the company's strategy and operations.

The management team of Alembic includes the following members:<BR><BR>1. **Chirayu R Amin** - Chairman (Non-Executive)<BR>2. **Malika C Amin** - Managing Director & CEO<BR>3. **C P Buch** - Independent Director<BR>4. **Udit Amin** - Director<BR>5. **Abhijit Joshi** - Director<BR>6. **Sameer Khera** - Independent Director<BR>7. **Drigesh Mittal** - Company Secretary & Compliance Officer<BR>8. **Rati Desai** - Independent Director<BR>9. **Mayank Amin** - Independent Director<BR>10. **Girish Hirode** - Independent Director<BR><BR>This team plays a crucial role in guiding the company's strategy and operations.

View full answer

What does Alembic do?

01-Sep-2026

Alembic Ltd is a manufacturer of bulk drugs and pharmaceuticals for human and animal healthcare, also involved in real estate, with a market cap of INR 2,496 Cr. As of June 2026, it reported net sales of 49 Cr and a net profit of 65 Cr.

Overview: <BR>Alembic Ltd is a manufacturer of bulk drugs and pharmaceuticals formulations in human and animal healthcare, operating in the Realty industry within the Small Cap market-cap bracket.<BR><BR>History: <BR>Alembic Ltd was incorporated in an unspecified year and has transitioned to include real estate in its operations. The latest quarterly results reported net sales and net profit for June 2026.<BR><BR>Financial Snapshot: <BR>Net Sales: 49 Cr (Quarterly Results - Jun 2026) <BR>Net Profit: 65 Cr (Quarterly Results - Jun 2026) <BR>Market Cap: INR 2,496 Cr (Small Cap)<BR><BR>Key Metrics: <BR>P/E: 8.00 <BR>Industry P/E: 37 <BR>Dividend Yield: 2.49% <BR>Debt-Equity: -0.04 <BR>Return on Equity: 12.98% <BR>Price to Book: 1.05<BR><BR>Contact Details: <BR>Address: Alembic Road, Vadodara Gujarat: 390003 <BR>Tel: 91-0265-2280550 <BR>Email: alembic.investors@alembic.co.in <BR>Website: http://www.alembiclimited.com

View full answer

Who are the peers of the Alembic?

01-Sep-2026

Alembic's peers include TARC Ltd, Arvind SmartSp., EFC (I), Elpro International, Marathon Nextgen, Hubtown, Omaxe, Arkade, and Ajmera Realty. In terms of management risk, growth, and capital structure, Arvind SmartSp. and EFC (I) show excellent performance, while Alembic has good growth and an excellent capital structure.

Peers: The peers of Alembic are TARC Ltd, Arvind SmartSp., EFC (I), Elpro Internatio, Marathon Nextgen, Hubtown, Omaxe, Arkade, and Ajmera Realty.<BR><BR>Quality Snapshot: Excellent management risk is observed at Arvind SmartSp., while Average management risk is found at EFC (I), Marathon Nextgen, Hubtown, Alembic, Arkade, Ajmera Realty, and the rest. Below Average management risk is noted for TARC Ltd, Elpro Internatio, and Omaxe. Excellent growth is seen at Arvind SmartSp. and EFC (I), while Good growth is observed at Alembic and PVP Ventures. Average growth is found at Marathon Nextgen, Ajmera Realty, and the rest, and Below Average growth is noted for TARC Ltd, Omaxe, Hubtown, Arkade, and the rest. Alembic has an Excellent capital structure, while Average capital structure is found at Marathon Nextgen and PVP Ventures, and Below Average capital structure is noted for TARC Ltd, EFC (I), Elpro Internatio, Hubtown, Omaxe, and Ajmera Realty.<BR><BR>Return Snapshot: The peer with the highest 1-year return is PVP Ventures at 226.82%, while the lowest is EFC (I) at -38.30%. Alembic's own 1-year return is -2.85%, which is higher than EFC (I) but lower than PVP Ventures. Additionally, Hubtown, EFC (I), and Ajmera Realty have negative six-month returns.

View full answer

How big is Alembic?

01-Sep-2026

As of 31st August, Alembic Ltd has a market capitalization of 2,496.00 Cr, with Net Sales of 238.98 Cr and a Net Profit of 320.64 Cr reported in the latest 4 quarters. Shareholder's Funds are 2,445.09 Cr and Total Assets are 2,589.51 Cr for the annual period ending March 2026.

As of 31st August, Alembic Ltd has a market capitalization of 2,496.00 Cr, categorizing it as a Small Cap company.<BR><BR>In the latest 4 quarters, Alembic reported Net Sales of 238.98 Cr and a Net Profit of 320.64 Cr.<BR><BR>For the latest annual period ending in March 2026, Alembic's Shareholder's Funds amounted to 2,445.09 Cr, while Total Assets were reported at 2,589.51 Cr.

View full answer

Are Alembic Ltd latest results good or bad?

20-May-2026

Alembic Ltd's latest Q4 FY26 results are concerning, with standalone net profit dropping 59.54% year-on-year and 57.23% quarter-on-quarter, indicating significant operational challenges. While consolidated net profit showed slight improvement, the overall financial metrics reflect declining profitability and efficiency, leading to a negative market reaction.

Alembic Ltd's latest results for Q4 FY26 indicate a challenging financial performance. The standalone net profit fell significantly by 59.54% year-on-year to ₹9.61 crores, and there was also a substantial decline of 57.23% compared to the previous quarter. This sharp drop reflects severe operational stress within the company.<BR><BR>On a consolidated basis, the net profit was ₹67.13 crores, which, while showing a slight decline of 1.93% year-on-year, did improve by 11.64% quarter-on-quarter. However, the overall picture remains concerning, as the standalone results are a critical indicator of the company's core operations.<BR><BR>The operating margin, excluding other income, dropped to 33.66%, marking the lowest level in eight quarters and a significant decrease from 45.35% in the same quarter last year. Additionally, net sales were nearly flat year-on-year, with a slight decline of 0.38%, but a more pronounced drop of 19.24% from the previous quarter.<BR><BR>Investors reacted negatively to these results, leading to a 2.96% decline in the stock price on the results day, and the stock has underperformed significantly over the past year, down 21.81%. Overall, the latest results suggest that Alembic Ltd is facing considerable operational challenges, and the financial metrics indicate a trend of declining profitability and efficiency.

View full answer

Is Alembic technically bullish or bearish?

02-Dec-2025

As of December 1, 2025, Alembic's technical trend is mildly bearish, with mixed signals from indicators like MACD, RSI, and Bollinger Bands suggesting a cautious outlook and short-term weakness.

As of 1 December 2025, the technical trend for Alembic has changed from bearish to mildly bearish. The current stance is mildly bearish overall, driven by mixed signals across various indicators. The MACD shows a mildly bullish trend on the weekly chart but is mildly bearish on the monthly chart. The RSI indicates a bullish signal on the monthly timeframe, while the weekly shows no signal. Bollinger Bands and KST are both mildly bearish on the weekly and monthly charts. Daily moving averages remain bearish, suggesting short-term weakness. Dow Theory indicates no trend in both weekly and monthly perspectives. Overall, the indicators reflect a cautious outlook with a slight bearish bias.

View full answer

How has been the historical performance of Alembic?

12-Nov-2025

Alembic has shown significant growth from March 2023 to March 2025, with net sales increasing from 127.24 Cr to 221.88 Cr, and profit after tax rising from 80.62 Cr to 144.57 Cr. The company also improved its operating profit margin to 42.23% and consolidated net profit to 310.68 Cr by March 2025.

Answer:<BR>The historical performance of Alembic shows significant growth in net sales and profitability over the years, particularly from March 2023 to March 2025.<BR><BR>Breakdown:<BR>Alembic's net sales have increased from 127.24 Cr in March 2023 to 221.88 Cr in March 2025, reflecting a strong upward trend. Total operating income has similarly risen, reaching 221.88 Cr in March 2025, up from 127.24 Cr in March 2023. The company's operating profit (PBDIT) has also shown substantial growth, climbing from 104.60 Cr in March 2023 to 168.60 Cr in March 2025, with an operating profit margin of 42.23% in March 2025, compared to 31.7% in March 2023. Profit before tax increased from 86.80 Cr in March 2023 to 155.51 Cr in March 2025, and profit after tax rose from 80.62 Cr to 144.57 Cr in the same period. The consolidated net profit reached 310.68 Cr in March 2025, up from 190.65 Cr in March 2023. On the balance sheet, total assets grew from 2,204.58 Cr in March 2023 to 2,503.00 Cr in March 2025, while total liabilities increased from 2,204.58 Cr to 2,503.00 Cr. Cash flow from operating activities improved significantly, rising to 86.00 Cr in March 2025 from 38.00 Cr in March 2023. Overall, Alembic has demonstrated a robust financial performance with increasing revenues, profits, and asset growth over the observed period.

View full answer

Who are the top shareholders of the Alembic?

17-Jul-2025

The top shareholders of Alembic include Nirayu Limited with 63.06%, 49 Foreign Institutional Investors holding 1.66%, and individual investors owning 21.94%. There are no mutual funds or public shareholders among the top holders.

The top shareholders of Alembic primarily consist of its promoters, with Nirayu Limited holding the largest stake at 63.06%. Additionally, there are 49 Foreign Institutional Investors (FIIs) who collectively hold 1.66% of the company. Individual investors also have a significant presence, owning 21.94% of the shares. Notably, there are no mutual funds currently invested in Alembic, and there are no public shareholders listed among the top holders.

View full answer

Is Alembic overvalued or undervalued?

09-Jun-2025

As of January 29, 2021, Alembic is considered very expensive and overvalued, with a PE ratio of 9.24, an EV to EBITDA of 30.14, and a year-to-date stock decline of 14.93%, indicating that its valuation does not align with industry standards despite comparable PE ratios to peers.

As of 29 January 2021, Alembic's valuation grade has moved from risky to very expensive, indicating a significant shift in its perceived value. The company is currently overvalued based on its financial metrics. Key ratios include a PE ratio of 9.24, an EV to EBITDA of 30.14, and a PEG ratio of 0.59, which suggest that while the earnings are relatively low compared to the price, the growth expectations are not sufficiently high to justify the current valuation.<BR><BR>When compared to peers in the realty sector, Alembic's PE ratio is on par with its competitors, but its EV to EBITDA ratio is notably high, indicating potential overvaluation. For instance, if we consider similar companies, they may have lower EV to EBITDA ratios, which could suggest that Alembic's pricing does not align with industry standards. Additionally, Alembic's recent stock performance shows a decline of 14.93% year-to-date, contrasting with a 5.60% rise in the Sensex, further reinforcing the notion that the stock may be overvalued in the current market environment.

View full answer

When is the next results date for Alembic?

06-Jun-2025

No Upcoming Board Meetings

What is the bonus history of the Alembic?

06-Jun-2025

Alembic Ltd had a bonus issue of 1:1 announced on September 27, 2013, with a record date of September 30, 2013, allowing shareholders to double their holdings by receiving an additional share for each share held.

Alembic Ltd has a bonus history that includes a 1:1 bonus issue announced with an ex-date of September 27, 2013. The record date for this bonus was September 30, 2013. This means that for every share held, shareholders received an additional share, effectively doubling their holdings at that time.

View full answer

Has Alembic declared dividend?

06-Jun-2025

Yes, Alembic Ltd has declared a dividend of 120%, amounting to ₹2.4 per share, with an ex-date of August 5, 2024. The company has shown strong long-term performance, particularly with a total return of 116.15% over the past five years.

Alembic Ltd has declared a dividend.<BR><BR>Dividend Details:<BR>- Percentage announced: 120%<BR>- Amount per share: 2.4<BR>- Ex-date: 05 Aug 24<BR><BR>Dividend Yield: 2.25%.<BR><BR>Total Returns by Period:<BR>In the 6-month period, the price return was -18.81%, with a dividend return of 0%, resulting in a total return of -18.81%.<BR><BR>For the 1-year period, the price return was 14.5%, the dividend return was 2.33%, leading to a total return of 16.83%.<BR><BR>Over the 2-year period, the price return was 63.92%, with a dividend return of 6.28%, culminating in a total return of 70.2%.<BR><BR>In the 3-year period, the price return was 63.4%, the dividend return was 10.83%, which resulted in a total return of 74.23%.<BR><BR>For the 4-year period, the price return was -10.93%, with a dividend return of 5.17%, leading to a total return of -5.76%.<BR><BR>In the 5-year period, the price return was 107.05%, the dividend return was 9.10%, resulting in a total return of 116.15%.<BR><BR>Overall, Alembic Ltd has declared a significant dividend of 120%, and while the total returns vary across different periods, the company has shown strong performance over the longer term, particularly in the 5-year period.

View full answer
iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Dashboard

1

The company is Net-Debt Free

 
2

Healthy long term growth as Operating profit has grown by an annual rate 48.23%

 
3

Negative results in Jun 26

4

With ROE of 13, it has a Very Expensive valuation with a 1.1 Price to Book Value

5

Despite the size of the company, domestic mutual funds hold only 0% of the company

stock-summaryMojo Parameters

Mojo Parameters

Loading Valuation Snapshot...

Stock DNA

stock-summary
Industry

Realty

stock-summary
Market cap

INR 2,681 Cr (Small Cap)

stock-summary
P/E

8.00

stock-summary
Industry P/E

37

stock-summary
Dividend Yield

2.44%

stock-summary
Debt Equity

-0.04

stock-summary
Return on Equity

12.98%

stock-summary
Price to Book

1.07

Revenue and Profits:
Net Sales:
49 Cr
(Quarterly Results - Jun 2026)
Net Profit:
65 Cr
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (2.44%)
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
15.07%
2.61%
17.68%
6 Months
29.59%
3.03%
32.62%
1 Year
-2.81%
2.40%
-0.41%
2 Years
-27.48%
3.36%
-24.12%
3 Years
31.9%
9.61%
41.51%
4 Years
52.15%
14.21%
66.36%
5 Years
-9.69%
9.90%
0.21%

Latest dividend: 2.3981072555205047 per share ex-dividend date: Aug-04-2026

Risk Adjusted Returns v/s stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryNews & Corporate Actions

News

Announcements stock-summary

Alembic Limited - Other General Purpose

15-Nov-2019 | Source : NSE

Alembic Limited has submitted to the Exchange a copy of Disclosure of Related Party Transactions pursuant to Regulation 23(9) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ( Listing Regulations, 2015 ).

Alembic Limited - Updates

06-Nov-2019 | Source : NSE

Alembic Limited has informed the Exchange regarding 'Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015'.

Price movement

24-Sep-2019 | Source : NSE

Significant movement in price has been observed in Alembic Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, had written to the company. Alembic Limited has submitted their response.

Corporate Actions stock-summary

stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

Alembic Ltd has declared 120% dividend, ex-date: 04 Aug 26

stock-summary
SPLITS

Alembic Ltd has announced 2:10 stock split, ex-date: 26 Sep 06

stock-summary
BONUS

Alembic Ltd has announced 1:1 bonus issue, ex-date: 27 Sep 13

stock-summary
RIGHTS

No Rights history available

stock-summaryKey Factors

Quality key factors stock-summary

Factor
Value
Sales Growth (5y)
24.17%
EBIT Growth (5y)
48.23%
EBIT to Interest (avg)
30.39
Debt to EBITDA (avg)
0.11
Net Debt to Equity (avg)
-0.04
Sales to Capital Employed (avg)
0.07
Tax Ratio
15.36%
Dividend Payout Ratio
19.84%
Pledged Shares
0
Institutional Holding
1.30%
ROCE (avg)
2.02%
ROE (avg)
11.43%

Valuation key factors

Factor
Value
P/E Ratio
8
Industry P/E
37
Price to Book Value
1.08
EV to EBIT
34.99
EV to EBITDA
29.69
EV to Capital Employed
1.09
EV to Sales
10.73
PEG Ratio
6.33
Dividend Yield
2.42%
ROCE (Latest)
3.31%
ROE (Latest)
12.98%

Technicals key factors

Indicator
Weekly
Monthly
MACD
Bullish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Bearish
Dow Theory
Mildly Bearish
No Trend
OBV
No Trend
Bullish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Jun 2026stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 1 Schemes (0.0%)

FIIs

Held by 42 FIIs (1.25%)

Promoter with highest holding

Nirayu Private Limited (63.06%)

Highest Public shareholder

Investors Education And Protection Fund (1.31%)

Individual Investors Holdings

22.23%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'26 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Jun 2026 is -2.03% vs -2.03% in Jun 2025",
        "dir": 0
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Jun 2026 is 5.27% vs 10.43% in Jun 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Jun'26",
        "Jun'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "48.74",
          "val2": "49.75",
          "chgp": "-2.03%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "15.46",
          "val2": "19.59",
          "chgp": "-21.08%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.60",
          "val2": "0.59",
          "chgp": "1.69%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "64.89",
          "val2": "61.64",
          "chgp": "5.27%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "31.72%",
          "val2": "39.38%",
          "chgp": "-7.66%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Consolidated) - Sep'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": " Growth in half year ended Sep 2025 is 1.84% vs 50.03% in Sep 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": " Growth in half year ended Sep 2025 is 7.52% vs 30.93% in Sep 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Sep'25",
        "Sep'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "105.61",
          "val2": "103.70",
          "chgp": "1.84%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "42.83",
          "val2": "39.98",
          "chgp": "7.13%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "1.15",
          "val2": "1.16",
          "chgp": "-0.86%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "190.13",
          "val2": "176.84",
          "chgp": "7.52%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "40.55%",
          "val2": "38.55%",
          "chgp": "2.00%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "header": "Nine Monthly Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in nine months ended Dec 2025 is 11.34% vs 49.04% in Dec 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in nine months ended Dec 2025 is 3.32% vs 23.30% in Dec 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "179.95",
          "val2": "161.62",
          "chgp": "11.34%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "70.27",
          "val2": "66.38",
          "chgp": "5.86%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "1.70",
          "val2": "1.85",
          "chgp": "-8.11%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "250.26",
          "val2": "242.23",
          "chgp": "3.32%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "39.05%",
          "val2": "41.07%",
          "chgp": "-2.02%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Mar'26",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2026 is 8.16% vs 40.89% in Mar 2025",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2026 is 2.16% vs 15.66% in Mar 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "239.99",
          "val2": "221.89",
          "chgp": "8.16%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "90.46",
          "val2": "93.71",
          "chgp": "-3.47%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "2.28",
          "val2": "2.47",
          "chgp": "-7.69%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "317.38",
          "val2": "310.68",
          "chgp": "2.16%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "37.69%",
          "val2": "42.23%",
          "chgp": "-4.54%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Jun'26 - YoYstock-summary

Jun'26
Jun'25
Change(%)
Net Sales
48.74
49.75
-2.03%
Operating Profit (PBDIT) excl Other Income
15.46
19.59
-21.08%
Interest
0.60
0.59
1.69%
Exceptional Items
0.00
0.00
Consolidate Net Profit
64.89
61.64
5.27%
Operating Profit Margin (Excl OI)
31.72%
39.38%
-7.66%
Values in Rs Cr.
Net Sales

YoY Growth in quarter ended Jun 2026 is -2.03% vs -2.03% in Jun 2025

Direction Arrows
Consolidated Net Profit

YoY Growth in quarter ended Jun 2026 is 5.27% vs 10.43% in Jun 2025

Half Yearly Results Snapshot (Consolidated) - Sep'25stock-summary

Sep'25
Sep'24
Change(%)
Net Sales
105.61
103.70
1.84%
Operating Profit (PBDIT) excl Other Income
42.83
39.98
7.13%
Interest
1.15
1.16
-0.86%
Exceptional Items
0.00
0.00
Consolidate Net Profit
190.13
176.84
7.52%
Operating Profit Margin (Excl OI)
40.55%
38.55%
2.00%
Values in Rs Cr.
Direction Arrows
Net Sales

Growth in half year ended Sep 2025 is 1.84% vs 50.03% in Sep 2024

Direction Arrows
Consolidated Net Profit

Growth in half year ended Sep 2025 is 7.52% vs 30.93% in Sep 2024

Nine Monthly Results Snapshot (Consolidated) - Dec'25stock-summary

Dec'25
Dec'24
Change(%)
Net Sales
179.95
161.62
11.34%
Operating Profit (PBDIT) excl Other Income
70.27
66.38
5.86%
Interest
1.70
1.85
-8.11%
Exceptional Items
0.00
0.00
Consolidate Net Profit
250.26
242.23
3.32%
Operating Profit Margin (Excl OI)
39.05%
41.07%
-2.02%
Values in Rs Cr.
Direction Arrows
Net Sales

YoY Growth in nine months ended Dec 2025 is 11.34% vs 49.04% in Dec 2024

Direction Arrows
Consolidated Net Profit

YoY Growth in nine months ended Dec 2025 is 3.32% vs 23.30% in Dec 2024

Annual Results Snapshot (Consolidated) - Mar'26stock-summary

Mar'26
Mar'25
Change(%)
Net Sales
239.99
221.89
8.16%
Operating Profit (PBDIT) excl Other Income
90.46
93.71
-3.47%
Interest
2.28
2.47
-7.69%
Exceptional Items
0.00
0.00
Consolidate Net Profit
317.38
310.68
2.16%
Operating Profit Margin (Excl OI)
37.69%
42.23%
-4.54%
Values in Rs Cr.
Direction Arrows
Net Sales

YoY Growth in year ended Mar 2026 is 8.16% vs 40.89% in Mar 2025

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Mar 2026 is 2.16% vs 15.66% in Mar 2025

stock-summaryCompany CV
About Alembic Ltd stock-summary
stock-summary
Alembic Ltd
Small Cap
Realty
Alembic Limited is one of the India's most experienced manufactures of bulk drugs and pharmaceuticals formulation in human and animal healthcare. The Company operates primarily in the manufacture of Bulk Drugs and Real Estate Business. The company manufacture pharmaceuticals and chemicals, bulk drugs (penicillin and other antibiotics) and formulations. It works manufacturing facilities at Vadodara in Gujarat and Solan in Himachal Pradesh.
Company Coordinates stock-summary
Company Details
Alembic Road , Vadodara Gujarat : 390003
stock-summary
Tel: 91-0265-2280550
stock-summary
alembic.investors@alembic.co.in
Registrar Details
Link Intime India Pvt Ltd., B-102 & B103, Shangrila Complex, First Floor, Opp: HDFC Bank, Near Radhakrishna Char Rasta, Akota, Vadodara